$1.6 Billion is the total value of Rock Springs Capital Management LP's 137 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 21.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | Buy | TESARO INC | $62,800,000 | +55.7% | 626,500 | +30.5% | 3.94% | +31.8% |
| AET | AETNA INC NEW | $50,810,000 | -5.5% | 440,100 | 0.0% | 3.18% | -20.0% | |
| RDUS | Buy | RADIUS HEALTH INC | $48,248,000 | +51.3% | 892,000 | +2.8% | 3.02% | +28.1% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $45,818,000 | -1.2% | 924,678 | +10.5% | 2.87% | -16.3% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $43,137,000 | +74.5% | 325,000 | +20.4% | 2.70% | +47.8% |
| AGN | Buy | ALLERGAN PLC | $42,838,000 | +2.4% | 186,000 | +2.7% | 2.68% | -13.3% |
| ONCE | Buy | SPARK THERAPEUTICS INC | $37,538,000 | +20.4% | 625,000 | +2.5% | 2.35% | +1.9% |
| MRK | New | MERCK & CO INC | $36,666,000 | – | 587,500 | +100.0% | 2.30% | – |
| PFE | PFIZER INC | $35,760,000 | -3.8% | 1,055,800 | 0.0% | 2.24% | -18.5% | |
| AAAP | Buy | ADVANCED ACCELERATOR APPLICsponsored ads | $35,414,000 | +27.2% | 930,000 | +1.0% | 2.22% | +7.7% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $32,749,000 | +19.1% | 267,250 | +13.5% | 2.05% | +0.8% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $32,617,000 | +12.1% | 45,000 | +2.3% | 2.04% | -5.1% |
| HCA | HCA HOLDINGS INC | $32,521,000 | -1.8% | 430,000 | 0.0% | 2.04% | -16.8% | |
| CI | Buy | CIGNA CORPORATION | $29,778,000 | +12.5% | 228,500 | +10.5% | 1.87% | -4.7% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $29,757,000 | +106.7% | 1,545,000 | +27.2% | 1.86% | +75.0% |
| WCG | WELLCARE HEALTH PLANS INC | $27,458,000 | +9.1% | 234,500 | 0.0% | 1.72% | -7.6% | |
| GILD | Buy | GILEAD SCIENCES INC | $27,217,000 | -5.1% | 344,000 | +0.1% | 1.71% | -19.6% |
| CELG | CELGENE CORP | $26,603,000 | +6.0% | 254,500 | 0.0% | 1.67% | -10.2% | |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $26,020,000 | +40.9% | 1,016,000 | +1.6% | 1.63% | +19.3% |
| MDCO | Buy | MEDICINES CO | $25,701,000 | +12.3% | 681,000 | +0.1% | 1.61% | -4.9% |
| SHPG | Buy | SHIRE PLCsponsored adr | $25,686,000 | +16.2% | 132,500 | +10.4% | 1.61% | -1.6% |
| ARDX | Buy | ARDELYX INC | $25,557,000 | +129.6% | 1,975,000 | +54.9% | 1.60% | +94.4% |
| LLY | LILLY ELI & CO | $22,152,000 | +1.9% | 276,000 | 0.0% | 1.39% | -13.7% | |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $21,744,000 | +36.9% | 600,000 | -14.3% | 1.36% | +15.9% |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $21,254,000 | +124.0% | 1,225,000 | -9.5% | 1.33% | +89.7% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $20,762,000 | +11.6% | 410,000 | +0.1% | 1.30% | -5.6% |
| PEN | Buy | PENUMBRA INC | $20,251,000 | +40.3% | 266,500 | +9.9% | 1.27% | +18.8% |
| PRTA | PROTHENA CORP PLC | $18,471,000 | +71.5% | 308,000 | 0.0% | 1.16% | +45.3% | |
| BIIB | Buy | BIOGEN INC | $18,156,000 | +30.2% | 58,000 | +0.6% | 1.14% | +10.3% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $17,247,000 | +8.2% | 504,000 | +6.7% | 1.08% | -8.4% |
| AMRN | New | AMARIN CORP PLCspons adr new | $15,809,000 | – | 4,955,746 | +100.0% | 0.99% | – |
| AMGN | AMGEN INC | $15,680,000 | +9.6% | 94,000 | 0.0% | 0.98% | -7.2% | |
| WMGI | Buy | WRIGHT MED GROUP N V | $15,037,000 | +58.0% | 613,000 | +11.9% | 0.94% | +33.8% |
| INCY | Buy | INCYTE CORP | $14,756,000 | +19.0% | 156,500 | +1.0% | 0.92% | +0.8% |
| PRAH | PRA HEALTH SCIENCES INC | $14,297,000 | +35.3% | 253,000 | 0.0% | 0.90% | +14.6% | |
| MCK | Buy | MCKESSON CORP | $13,674,000 | -6.0% | 82,000 | +5.3% | 0.86% | -20.4% |
| GLPG | GALAPAGOS NVspon adr | $13,579,000 | +16.6% | 210,000 | 0.0% | 0.85% | -1.3% | |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $13,480,000 | -6.7% | 250,000 | +27.2% | 0.84% | -21.0% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $12,998,000 | -9.8% | 107,000 | +4.9% | 0.82% | -23.6% |
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $12,980,000 | -2.8% | 161,000 | +0.4% | 0.81% | -17.7% |
| DHR | New | DANAHER CORP DEL | $12,542,000 | – | 160,000 | +100.0% | 0.79% | – |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $12,520,000 | +85.3% | 467,500 | +16.9% | 0.78% | +57.0% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $12,448,000 | +49.5% | 103,250 | +23.7% | 0.78% | +26.6% |
| TXMD | Buy | THERAPEUTICSMD INC | $12,258,000 | -8.4% | 1,800,000 | +14.3% | 0.77% | -22.5% |
| DERM | Buy | DERMIRA INC | $12,006,000 | +15.7% | 355,000 | +0.0% | 0.75% | -2.1% |
| PTHN | New | PATHEON N V | $11,852,000 | – | 400,000 | +100.0% | 0.74% | – |
| RTRX | Buy | RETROPHIN INC | $11,682,000 | +25.8% | 522,000 | +0.1% | 0.73% | +6.6% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $11,565,000 | +31.6% | 125,000 | +10.6% | 0.72% | +11.4% |
| HLS | HEALTHSOUTH CORP | $10,751,000 | +4.5% | 265,000 | 0.0% | 0.67% | -11.5% | |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $10,660,000 | +4.1% | 1,316,000 | +0.3% | 0.67% | -11.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $10,624,000 | +325.3% | 173,000 | +32.1% | 0.67% | +260.0% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $10,428,000 | +50.7% | 147,000 | +3.9% | 0.65% | +27.7% |
| HOLX | Buy | HOLOGIC INC | $9,805,000 | +23.2% | 252,500 | +9.8% | 0.62% | +4.4% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $8,726,000 | +37.9% | 166,250 | +8.7% | 0.55% | +16.9% |
| BOLD | New | AUDENTES THERAPEUTICS INC | $8,638,000 | – | 485,000 | +100.0% | 0.54% | – |
| ALKS | Sell | ALKERMES PLC | $8,608,000 | +2.4% | 183,027 | -5.9% | 0.54% | -13.2% |
| EXAS | New | EXACT SCIENCES CORP | $8,078,000 | – | 435,000 | +100.0% | 0.51% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $7,827,000 | +6.4% | 89,750 | +5.0% | 0.49% | -9.9% |
| NVTA | Buy | INVITAE CORP | $7,796,000 | +22.9% | 890,000 | +3.7% | 0.49% | +4.0% |
| WLTW | New | WILLIS TOWERS WATSON PUB LTD | $7,767,000 | – | 58,500 | +100.0% | 0.49% | – |
| HRC | HILL ROM HLDGS INC | $7,438,000 | +22.9% | 120,000 | 0.0% | 0.47% | +4.0% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $7,403,000 | +15.4% | 450,000 | 0.0% | 0.46% | -2.3% | |
| INSM | Buy | INSMED INC | $7,304,000 | +48.9% | 503,000 | +1.1% | 0.46% | +26.2% |
| PTI | Buy | PROTEOSTASIS THERAPEUTICS IN | $7,016,000 | +39.4% | 450,000 | +8.4% | 0.44% | +18.0% |
| BGNE | BEIGENE LTDsponsored adr | $6,932,000 | +3.4% | 225,000 | 0.0% | 0.44% | -12.3% | |
| REGN | REGENERON PHARMACEUTICALS | $6,834,000 | +15.1% | 17,000 | 0.0% | 0.43% | -2.7% | |
| OPHT | Buy | OPHTHOTECH CORP | $6,827,000 | -6.1% | 148,000 | +3.9% | 0.43% | -20.4% |
| MGNX | MACROGENICS INC | $6,730,000 | +10.8% | 225,000 | 0.0% | 0.42% | -6.2% | |
| EGALET CORPnote 5.500% 4/0 | $6,684,000 | +12.8% | 7,800,000 | 0.0% | 0.42% | -4.3% | ||
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $6,643,000 | +70.2% | 1,810,000 | +3.4% | 0.42% | +43.9% |
| LGND | New | LIGAND PHARMACEUTICALS INC | $6,634,000 | – | 65,000 | +100.0% | 0.42% | – |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $6,538,000 | +12.3% | 502,500 | +20.1% | 0.41% | -4.9% |
| EVHC | ENVISION HEALTHCARE HLDGS IN | $6,481,000 | -12.2% | 291,000 | 0.0% | 0.41% | -25.8% | |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $6,421,000 | +17.6% | 555,000 | 0.0% | 0.40% | -0.2% | |
| MRUS | Buy | MERUS N V | $6,415,000 | +122.5% | 383,000 | +6.1% | 0.40% | +88.7% |
| EPZM | Buy | EPIZYME INC | $6,322,000 | +3.3% | 642,500 | +7.5% | 0.40% | -12.6% |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $6,030,000 | +51.5% | 300,000 | 0.0% | 0.38% | +28.1% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $5,964,000 | +32.3% | 182,000 | +0.8% | 0.37% | +12.0% |
| JUNO | JUNO THERAPEUTICS INC | $5,912,000 | -21.9% | 197,001 | 0.0% | 0.37% | -33.9% | |
| RTIX | RTI SURGICAL INC | $5,822,000 | -12.8% | 1,860,000 | 0.0% | 0.36% | -26.1% | |
| AVXS | Sell | AVEXIS INC | $5,769,000 | +6.3% | 140,000 | -1.9% | 0.36% | -10.0% |
| ATHN | ATHENAHEALTH INC | $5,770,000 | -8.6% | 45,750 | 0.0% | 0.36% | -22.5% | |
| GI | Buy | ENDOCHOICE HLDGS INC | $5,766,000 | +65.7% | 722,500 | +1.8% | 0.36% | +39.9% |
| XENT | Buy | INTERSECT ENT INC | $5,465,000 | +24.3% | 345,000 | +1.5% | 0.34% | +5.5% |
| CGEN | Buy | COMPUGEN LTDord | $5,198,000 | -2.2% | 825,000 | +0.6% | 0.33% | -17.0% |
| ADRO | ADURO BIOTECH INC | $5,158,000 | +9.9% | 415,000 | 0.0% | 0.32% | -7.2% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $5,143,000 | +38.5% | 695,000 | +2.2% | 0.32% | +17.1% |
| FGEN | Buy | FIBROGEN INC | $4,833,000 | +30.9% | 233,500 | +3.8% | 0.30% | +11.0% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,759,000 | -23.7% | 675,000 | -11.8% | 0.30% | -35.5% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $4,660,000 | +374.1% | 69,500 | +110.6% | 0.29% | +300.0% |
| TNDM | TANDEM DIABETES CARE INC | $4,558,000 | +1.6% | 595,000 | 0.0% | 0.29% | -13.9% | |
| CLVS | CLOVIS ONCOLOGY INC | $4,506,000 | +162.7% | 125,000 | 0.0% | 0.28% | +122.0% | |
| CO | CHINA CORD BLOOD CORP | $4,497,000 | -11.1% | 880,000 | 0.0% | 0.28% | -24.8% | |
| KITE | Sell | KITE PHARMA INC | $4,413,000 | +10.3% | 79,000 | -1.2% | 0.28% | -6.4% |
| AIMT | AIMMUNE THERAPEUTICS INC | $4,395,000 | +38.6% | 293,000 | 0.0% | 0.28% | +17.4% | |
| BIOS | New | BIOSCRIP INC | $4,308,000 | – | 1,490,492 | +100.0% | 0.27% | – |
| AGNPRA | ALLERGAN PLCpfd conv ser a | $4,106,000 | -1.4% | 5,000 | 0.0% | 0.26% | -16.6% | |
| MEDP | New | MEDPACE HLDGS INC | $4,031,000 | – | 135,000 | +100.0% | 0.25% | – |
| NVLS | NIVALIS THERAPEUTICS INC | $3,976,000 | +76.8% | 489,000 | 0.0% | 0.25% | +50.0% | |
| MEDICINES COnote 2.500% 1/1 | $3,898,000 | +9.8% | 3,000,000 | 0.0% | 0.24% | -7.2% | ||
| OTIC | Sell | OTONOMY INC | $3,820,000 | +0.2% | 210,000 | -12.5% | 0.24% | -15.2% |
| CRME | CARDIOME PHARMA CORP | $3,751,000 | -38.9% | 1,200,000 | 0.0% | 0.24% | -48.4% | |
| INVA | INNOVIVA INC | $3,703,000 | +4.4% | 336,900 | 0.0% | 0.23% | -11.8% | |
| PRGO | PERRIGO CO PLC | $3,499,000 | +1.8% | 37,900 | 0.0% | 0.22% | -13.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $3,359,000 | +31.9% | 524,089 | 0.0% | 0.21% | +11.6% | |
| MD | Sell | MEDNAX INC | $3,313,000 | -76.5% | 50,000 | -74.4% | 0.21% | -80.1% |
| NBRV | NABRIVA THERAPEUTICS AGsponsored adr | $3,003,000 | -6.0% | 426,000 | 0.0% | 0.19% | -20.7% | |
| STE | STERIS PLC | $2,924,000 | +6.3% | 40,000 | 0.0% | 0.18% | -10.3% | |
| ITCI | INTRA CELLULAR THERAPIES INC | $2,896,000 | -60.7% | 190,000 | 0.0% | 0.18% | -66.7% | |
| CDTX | CIDARA THERAPEUTICS INC | $2,863,000 | +11.1% | 250,000 | 0.0% | 0.18% | -6.3% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $2,812,000 | +29.9% | 390,000 | 0.0% | 0.18% | +10.0% | |
| MCRB | Sell | SERES THERAPEUTICS INC | $2,704,000 | -64.5% | 220,000 | -16.0% | 0.17% | -69.8% |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $2,652,000 | +11.4% | 73,000 | 0.0% | 0.17% | -5.7% | |
| TTPH | Buy | TETRAPHASE PHARMACEUTICALS I | $2,537,000 | +38.8% | 662,500 | +55.9% | 0.16% | +17.8% |
| GNCA | GENOCEA BIOSCIENCES INC | $2,458,000 | +24.9% | 480,000 | 0.0% | 0.15% | +5.5% | |
| SCYX | SCYNEXIS INC | $2,457,000 | +78.3% | 635,000 | 0.0% | 0.15% | +51.0% | |
| EGLTQ | EGALET CORP | $2,283,000 | +53.4% | 300,000 | 0.0% | 0.14% | +30.0% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $2,259,000 | +38.9% | 98,000 | 0.0% | 0.14% | +18.3% | |
| AMSG | New | AMSURG CORP | $2,179,000 | – | 32,500 | +100.0% | 0.14% | – |
| DMTX | DIMENSION THERAPEUTICS INC | $2,168,000 | +33.2% | 271,370 | 0.0% | 0.14% | +12.4% | |
| NVCR | NOVOCURE LTD | $1,830,000 | -26.8% | 214,316 | 0.0% | 0.12% | -37.8% | |
| NVAX | NOVAVAX INC | $1,773,000 | -71.4% | 852,500 | 0.0% | 0.11% | -75.8% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $1,731,000 | -28.1% | 165,000 | 0.0% | 0.11% | -38.8% | |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $1,684,000 | +26.5% | 68,600 | +3.8% | 0.11% | +7.1% |
| EXEL | New | EXELIXIS INC | $1,599,000 | – | 125,000 | +100.0% | 0.10% | – |
| CHMA | CHIASMA INC | $1,448,000 | +1.8% | 492,500 | 0.0% | 0.09% | -13.3% | |
| ANTH | ANTHERA PHARMACEUTICALS INC | $1,418,000 | +1.9% | 450,000 | 0.0% | 0.09% | -13.6% | |
| LIFE | ATYR PHARMA INC | $1,379,000 | +14.4% | 433,500 | 0.0% | 0.09% | -3.4% | |
| BLUE | BLUEBIRD BIO INC | $1,356,000 | +56.6% | 20,000 | 0.0% | 0.08% | +32.8% | |
| CERN | CERNER CORP | $1,235,000 | +5.4% | 20,000 | 0.0% | 0.08% | -11.5% | |
| INSYQ | Sell | INSYS THERAPEUTICS INC NEW | $1,179,000 | -75.1% | 100,000 | -72.6% | 0.07% | -78.9% |
| WRIGHT MED GROUP INCnote 2.000% 2/1 | $1,073,000 | +16.8% | 1,000,000 | 0.0% | 0.07% | -1.5% | ||
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $799,000 | – | 63,000 | +100.0% | 0.05% | – |
| CERU | CERULEAN PHARMA INC | $654,000 | -50.6% | 625,000 | 0.0% | 0.04% | -58.2% | |
| OREXQ | New | OREXIGEN THERAPEUTICS INC | $549,000 | – | 165,300 | +100.0% | 0.03% | – |
| INFI | INFINITY PHARMACEUTICALS INC | $421,000 | +17.3% | 270,000 | 0.0% | 0.03% | -3.7% | |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $342,000 | – | 25,000 | +100.0% | 0.02% | – |
| MIRN | Exit | MIRNA THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.05% | – |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -1,653,000 | -100.0% | -0.05% | – |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -490,000 | -100.0% | -0.08% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -75,000 | -100.0% | -0.10% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -10,000 | -100.0% | -0.11% | – |
| INOV | Exit | INOVALON HLDGS INC | $0 | – | -104,302 | -100.0% | -0.14% | – |
| TSRO | Exit | TESARO INCcall | $0 | – | -40,000 | -100.0% | -0.25% | – |
| EARS | Exit | AURIS MED HLDG AG | $0 | – | -850,000 | -100.0% | -0.26% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -175,000 | -100.0% | -0.31% | – |
| Exit | CORSICANTO LTDnote 3.500% 1/1 | $0 | – | -7,000,000 | -100.0% | -0.53% | – | |
| ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -250,000 | -100.0% | -0.54% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -1,195,000 | -100.0% | -0.62% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -100,200 | -100.0% | -1.10% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -311,000 | -100.0% | -1.33% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -395,000 | -100.0% | -1.47% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.